The Competition Tribunal dismissed the lawsuit by Bayer HealthCare LLC against Laboratorio Maver Ltda. and its representative, Mr. Alberto Albala Weissman, for alleged disloyal competition actions that would have consisted in an alleged abuse of legal actions, destined to prevent the entry of the TABCIN line of products to the national market. The Competition Tribunal declared that Bayer HealthCare LLC had to pay Tribunal costs.
The Tribunal concluded that the founding facts of the lawsuit could not alter the conclusions of Decision No. 60/2007, that solved a previous lawsuit between the same parties, and that they were not suitable for configuring an infraction to Article 3 of the Competition Act.